What is the rationale for using non-calcium-based phosphate binders in CKD?

• A. To lower phosphate without adding calcium load and thus avoid vascular calcification risk.
• B. To increase calcium absorption from the gut.
• C. To raise serum phosphate for bone mineralization.
• D. To directly suppress PTH secretion.

Answer: (C)

In CKD, the goal is to lower gut phosphate absorption without adding calcium to the body, because excess calcium can drive vascular calcification. Non-calcium–based phosphate binders bind dietary phosphate in the intestine and prevent its absorption, reducing serum phosphate and the calcium-phosphate product without increasing circulating calcium. This helps minimize vascular and soft-tissue calcification risk, especially in patients with hypercalcemia or high calcification risk. Calcium-based binders can control phosphate but add calcium, potentially worsening calcification, so avoiding extra calcium is advantageous. The binder’s job is to reduce phosphate burden rather than raise phosphate for bone mineralization or directly suppress PTH.